Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
71 hedge funds and large institutions have $53.9M invested in Applied Genetic Technologies Corporation in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 31 reducing their positions, and 24 closing their positions.
194% more call options, than puts
Call options by funds: $3.28M | Put options by funds: $1.12M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 82 → 71 (-11)
42% less capital invested
Capital invested by funds: $93.2M → $53.9M (-$39.3M)
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
58% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.49M |
| 2 |
E
Ergoteles
New York
|
+$771K |
| 3 |
HF
HRT Financial
New York
|
+$519K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$519K |
| 5 |
Morgan Stanley
New York
|
+$512K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$8.1M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$4.4M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.46M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.18M |
| 5 |
Renaissance Technologies
New York
|
-$1.82M |
AGTC Hedge Fund Activity: Q2 2021 in Review
71 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2021, worth a combined $53.9M — down 42% from $93.2M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of AGTC and 13 opened new positions — a net loss of 11 holders — while 31 trimmed existing stakes and 13 added.
The largest buyer was Millennium Management, adding an estimated $3.49M. The largest seller was BlackRock, cutting an estimated $8.1M.
- 71 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2021, down from 82 in Q1 2021.
- Funds reported $53.9M of Applied Genetic Technologies Corporation stock for Q2 2021, down 42% quarter-over-quarter.
- 13 funds opened new Applied Genetic Technologies Corporation positions in Q2 2021 and 24 closed out, a net change of -11 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q2 2021 was Millennium Management, an estimated $3.49M added.
- The largest Applied Genetic Technologies Corporation seller in Q2 2021 was BlackRock, an estimated $8.1M sold.
Based on aggregated 13F filings for Q2 2021.